These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21609664)

  • 1. [Could we cure type 1 diabetes by stimulating T(reg)?].
    Grinberg-Bleyer Y; Baeyens A; Piaggio E; Salomon BL
    Med Sci (Paris); 2011 May; 27(5):471-2. PubMed ID: 21609664
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose IL-2 as a therapeutic agent for tolerance induction.
    Malek TR; Pugliese A
    Immunotherapy; 2011 Nov; 3(11):1281-4. PubMed ID: 22053878
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
    Qin HY; Chaturvedi P; Singh B
    Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells.
    Kaminitz A; Mizrahi K; Yaniv I; Stein J; Askenasy N
    J Autoimmun; 2010 Sep; 35(2):145-52. PubMed ID: 20638242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons from mouse models and implications for human disease.
    Sgouroudis E; Piccirillo CA
    Diabetes Metab Res Rev; 2009 Mar; 25(3):208-18. PubMed ID: 19214972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
    Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
    Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
    Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
    Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
    Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
    Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for the prevention and treatment of type 1 diabetes.
    Goudy KS; Tisch R
    Int Rev Immunol; 2005; 24(5-6):307-26. PubMed ID: 16318984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice.
    Pacheco-Silva A; Bastos MG; Muggia RA; Pankewycz O; Nichols J; Murphy JR; Strom TB; Rubin-Kelley VE
    Eur J Immunol; 1992 Mar; 22(3):697-702. PubMed ID: 1547815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD3-specific antibodies: a portal to the treatment of autoimmunity.
    Chatenoud L; Bluestone JA
    Nat Rev Immunol; 2007 Aug; 7(8):622-32. PubMed ID: 17641665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of TNF-alpha in the development of autoimmunity and the pathogenesis of insulin-dependent diabetes mellitus in NOD mice.
    Yang XD; McDevitt HO
    Circ Shock; 1994 Aug; 43(4):198-201. PubMed ID: 7895326
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity.
    Qin HY; Mukherjee R; Lee-Chan E; Ewen C; Bleackley RC; Singh B
    Int Immunol; 2006 Jul; 18(7):1001-15. PubMed ID: 16675487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both central and peripheral tolerance mechanisms play roles in diabetes prevention in NOD-E transgenic mice.
    Mellanby RJ; Phillips JM; Parish NM; Cooke A
    Autoimmunity; 2008 Aug; 41(5):383-94. PubMed ID: 18568644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoid hyperplasia, CD45RBhigh to CD45RBlow T-cell imbalance, and suppression of Type I diabetes mellitus result from TNF blockade in NOD-->NOD-scid adoptive T cell transfer.
    Brown GR; Silva MD; Thompson PA; Beutler B
    Diabetologia; 1998 Dec; 41(12):1502-10. PubMed ID: 9867218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
    Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
    Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells--the renaissance of the suppressor T cells.
    Bopp T; Jonuleit H; Schmitt E
    Ann Med; 2007; 39(5):322-34. PubMed ID: 17701475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.